Activation of HIV-1 requires the binding of host cell transcription factors to cis elements in the proviral long terminal repeat (LTR). This study identifies c-fos-responsive sequence motifs in the U5 transcribed noncoding leader sequences downstream of the viral transactivator responsive (TAR) element. These DNA sequence motifs are the most downstream regulatory elements described thus far in the HIV-1 LTR. Functional studies, using human colon epithelial cell 
tory elements in the LTR promoter (4) . Transcriptional studies of the HIV-1 genome indicate that the HIV-l LTR promoter can be subdivided into three functional domains: a basal core promoter, which is comprised of the transcriptional start site, a TATA box, and three tandem Spl binding sites (GCboxes); an upstream enhancer element containing two adjacent binding sites for the inducible transcriptional activator nuclear factor kappa B (NFKB); and a far upstream modulatory region (4, 5) . The HIV-l LTR promoter also contains several recognition sites for nucleic acid binding proteins downstream ofthe transcriptional start site (6) . However, with the exception of the transactivator responsive (TAR) element, which, upon transcription into a specific RNA structure, binds the viral transactivator protein Tat, the importance of these downstream sequence motifs or their role in HIV-1 gene expression has not been demonstrated.
HIV-1 is associated with disease of the immune, nervous, and digestive systems ( 1, 7, 8) . Infected epithelial and other cell types in the gastrointestinal tract are potential reservoirs of HIV-1 and may contribute to the pathophysiology ofdiarrheal syndromes in HIV-l-infected individuals (9) (10) (11) (12) (13) (14) (15) (16) (17) . Recently, we reported differences among three human colonic epithelial cell lines, SW620, HT29, and T84, with respect to their expression ofthe CD4/HIV-1 receptor, HIV-l infectivity and replication, and activation of the HIV-1 LTR by protein kinase C (PKC) activators ( 18) . Thus, transcriptional activation of the HIV-1 LTR was stimulated by phorbol esters (phorbol 12-myristate 13-acetate [PMA] ) and the proinflammatory cytokine TNFa in the HIV-1 infectible SW620 and HT29 cell lines, but not in the noninfectible T84 colon epithelial cell line ( 18) . Although mutational analysis indicated that increased transcriptional activity of the HIV-1 LTR in SW620 and HT29 cells was due, at least in part, to activation ofthe NFKB-binding enhancer elements ( 18) , the same agonists are also known to activate other sequence-specific DNA binding proteins, including the transcription factor activator protein-1 (AP-1 ) ( 19) .
AP-1 is a member of a class of DNA binding proteins encoded by a multigene family of nuclear protooncogenes that mediate cellular responses to growth factors, regulatory cytokines, and tumor-promoting PMA via an AP-l binding site, termed a TRE (for TPA/PMA-responsive element) (19) (20) (21) (22) (23) . The AP-1 binding site or TRE is recognized by dimeric protein complexes composed of Jun homodimers or Jun/Fos heterodimers ( 19, 24) . The Fos component of AP-1 does not itself 1. Abbreviations used in this paper: AP-1, activator protein-l; ATF, activating transcription factor; CAT, chloramphenicol acetyltransferase; CRE, cAMP responsive element; CREB, CRE binding protein; bind the TRE because of an inability to form homodimers, but in the presence of Jun, Fos forms a Fos/Jun heterodimer complex of greater stability than Jun/Jun homodimers (25) (26) (27) . Several TRE-like motifs, some ofwhich bind c-Fos-containing complexes, have been identified in the upstream modulatory region of the HIV-I LTR (24, 28) . However, a functional role for c-Fos or AP-1 in either positive or negative regulation of HIV-1 gene expression has not been demonstrated.
The cAMP-responsive element (CRE) binding protein/activating transcription factor (CREB/ATF) family of cellular transcription factors is a closely related class of transcription factors with members that are structurally similar to members ofthe Jun/Fos family. Like Jun/Fos family members, CREB/ ATF family members can also interact with each other to form dimers that recognize the CRE, a sequence similar to the TPA/ PMA responsive element (TRE) (29) (30) (31) . Recent studies have shown that members of the Jun/Fos family can combine with certain members of the CREB/ATF family, via their leucine zipper dimerization domains, to form cross-family heterodimers that preferentially bind to CRE-like motifs (32) (33) (34) (35) . For example, c-Fos and c-Jun can cross-combine with several different ATF transcription factors (36) . The ability to form such cross-family dimers increases the repertoire ofprotein factors available for gene regulation.
In this study, we identify functional TRE/CRE-like sequence motifs within the U5 region ofthe HIV-l LTR. Expression studies in human colon epithelial cell Plasmids and synthetic deoxyoligonucleotides. The HIV-1 -91/ +232 LTR chloramphenicol acetyltransferase (CAT) reporter plasmid was previously described (37) . It consists of91 bp ofHIV-I LTR sequences upstream of the transcriptional initiation site (+ 1) and 232 bp of LTR sequences downstream of transcription, extending into the U5 region of the LTR, linked to a CAT reporter gene. The -91 /+232AS LTR CAT plasmid was derived from the -91/+232 construction by excising an internal 183 bp SstI fragment from nucleotide position +39 to +222. The -91/+232 M6 LTR CAT plasmid was constructed in two steps by using cassette mutagenesis. In the first step, an interim mutational plasmid (pBS-HIV-SstIM) was constructed by cloning a mutant oligonucleotide cassette into a pBluescript II vector (Stratagene, Inc., San Diego, CA) to yield a plasmid containing LTR wild-type sequences from +39 to +222 except for several point mutations around + 160 and +95. The base pair changes (see Fig. 3 A) introduced into the two motifs were designed to create two new restriction enzyme recognition sites, a BssHII site at + 160 and a NotI site at +95, as well as disrupt the nucleotide sequence homologies to TRE and CRE motifs in those regions. These mutations also do not appreciably alter the predicted RNA secondary structure of the transcribed noncoding 5' leader sequence. Mutations in pBS-HIV-SstIM were identified by restriction digestions with BssHII and NotI and were verified by dideoxynucleotide sequencing. For the second step of the mutagenesis, a 183-bp SstI restriction fragment from pBS-HIV-SstIM was cloned back into its original HIV-I context to obtain the -91 / +232M6 LTR CAT reporter plasmid (see Fig. 3 A) . The correct transcriptional orientation of the cloned fragment in the -91 /+232M6 plasmid was determined by restriction analysis and confirmed functionally with a Tat cotransfection assay (see Fig. 3 B) .
The expression plasmids RSV-c-jun, SV-c-fos, SV-fosB, RSVjunB, and RSV-NFl have been described previously (20, 28, 38, 39) .
The SV-tat expression plasmid, provided by A. B. Rabson (Center for Advanced Biotechnology and Medicine, Piscataway, NJ), contains the first exon of the HIV-l tat gene driven by the SV40 early promoter (40) . The HIV-1 firefly luciferase reporter gene plasmid (HIV-l-LUC), provided by A. Siddiqui (University of Colorado, Denver), contains complete LTR promoter sequences upstream of +80 (41) . The TRE luciferase reporter gene plasmid (TRE/AP-1-LUC), provided by M. G. Rosenfeld (University of California, San Diego), consists of two pairs of consensus TRE motifs upstream of a rat prolactin minimal promoter containing a TATA box (see Fig. 5 A) (42) . Plasmids used as negative controls (e.g., RSV-fgal, SV-fgal, and RSV-neo)
were described previously (43) . Deoxyoligonucleotides were synthesized using a Milligen DNA synthesizer (Millipore Corp., Novato, CA) and purified as specified by the manufacturer. The Spl and NFl oligonucleotides were described previously (39) . Other oligonucleotides used in these studies are listed in Table I . To produce DNA gel shift probes, oligonucleotides were made double stranded by annealingthe single-stranded complementary oligonucleotides and end labeling with ["32P]ATP (3,000 Ci/mmol) and T4 polynucleotide kinase.
Cell culture, transient transfections, and reporter gene assays. Human colon epithelial cell lines SW620, HT29, and T84 were obtained, maintained, and transfected as previously described ( 18) . For stimulation, cells were treated 16-20 h after transfection with optimal concentrations of human recombinant TNFa (20 ng/ml) (Genentech Inc., South San Francisco, CA) or PMA (20 ng/ml) (Sigma Chemical Co., St. Louis, MO) for 16 to 20 h. CAT (EC 2.3.1.28) and firefly luciferase (26) . Briefly, purified bacterially expressed trpE-c-Jun fusion protein (10 ng/,gl) (26) addition to NFKB/rel, cellular factors in the Jun/Fos family of transcription factors, we asked whether AP-l proteins play a role in transcriptional activation of the HIV-1 LTR. Several AP-I binding sites had been identified before, upstream of the NFKB binding sites, but a functional role for these motifs has thus far not been demonstrated (24, 28, 45) .
We describe herein that there also are previously unrecognized AP-1-like binding sites in the HIV-1 LTR downstream of the promoter in the transcribed noncoding 5' leader sequence. At least two distinct regions, one centered at nucleotide position +95 and the other at + 160 in the 5' untranslated leader sequences downstream of TAR, exhibit a high degree of sequence similarity to classical TRE and CRE motifs (Fig. 1  A) . To assess whether these newly recognized DSE might contribute to activation ofthe HIV-1 LTR, we performed transient cotransfection experiments with a truncated HIV-l LTR reporter gene plasmid, -91/+232 LTR CAT, which contains HIV-1 LTR sequences from nucleotide position -91 to +232 (relative to the viral transcription initiation site) coupled to a CAT reporter gene ( Fig. 1 A) . Unlike LTR CAT constructions that contain upstream AP-1 binding sites and a functional HIV-1 enhancer element with two NFKB-binding sites, the -91/+232 LTR CAT plasmid has only the 3' NFKB binding site intact and, compared with a construction with both NFKBbinding sites ( 18) , is only weakly expressed when cotransfected into SW620 cells with a control RSV-neo expression plasmid ( Fig. 1 B, lane 1). Consistent with our previous results, this enhancer mutant construction exhibited little or no response to the PKC activators PMA and TNFa, respectively ( Fig. 1 B, lanes 1-3).
As shown in Fig. 1 , we first tested whether c-Fos, a major component of AP-1 complexes, could stimulate HIV-1 LTR gene transcription in the absence of an intact HIV-1 enhancer and upstream AP-1 binding sites. For these studies, the -91 / +232 reporter plasmid was cotransfected into the HIV-1 infectible colon epithelial cell line SW620, together with an expression vector that produces c-Fos. When the -91 / +232 reporter plasmid was cotransfected with the c-fos expression plasmid, HIV-1 LTR reporter gene activity increased ( 12) shows results using the -91 / +232 construction transfected into SW620 cells. The bottom panel (lanes [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] shows parallel results with the -91/+232AS deletional mutation, which is identical in structure to the -91/+232 plasmid except for the deletion of sequences between the two SstI sites at +39 and +222 (see Fig. 1 The HIV-J LTR contains c-Fos-responsive elements downstream of TAR. The observation that c-Fos, in concert with PMA or TNFa, stimulated HIV-1 LTR-mediated CAT activity suggested that the HIV-1 LTR contained a TRE or CRE element downstream of the HIV-1 enhancer. We first tested whether a deletion of the TRE/CRE-like LTR sequences encompassing the downstream TRE/CRE-like motifs centered at nucleotide positions +95 and + 160 would alter the c-Fos transactivation effect documented in Fig. 1 . The construction used had a deletion between two SstI restriction sites from +39 to +222 in the -91/+232 LTR CAT construction. In cotransfection experiments (Fig. 2, top) , the wild-type -91 / +232 construction, as indicated previously ( (Fig.  2, compare lanes 7-9 and 19-21) . FosB, another member of the fos gene family (27) , was unable to significantly stimulate LTR-ediated CAT activity in SW620 cells (see Fig. 2 , lanes 10-12 and 22-24).
Point mutations in the +160 and +95 TRE/CRE-like motifs abrogate c-Fos transactivation ofHIV-I gene expression. To demonstrate whether the TRE/CRE-like motifs at +160 and +95 were important for c-Fos transactivation ofthe HIV-1 LTR, we introduced cluster point mutations into these DSE. Unlike the wild-type reporter gene (Fig. 3 B, lanes 3 and 4) , when the -91 /+232M6 construction containing mutations in the +95 and +160 DSE motifs was transfected into SW620 cells, no detectable transactivation of the HIV-1 LTR was observed with cotransfection of a c-Fos-expressing plasmid in either untreated or PMA-treated cells (Fig. 3 B, lanes 7 and 8) . In contrast, a cotransfected Tat expression plasmid strongly stimulated the -91/+232M6 reporter gene construction in PMA-treated (Fig. 3, lane 9 ) and untreated SW620 colon epithelial cells (data not shown). The cluster mutations had little or no effect on (Fig. 4) tion, TRE/AP1-LUC, to be activated by PMA in T84 cells. This construction (Fig. 5 A) contains multiple consensus TRE motifs upstream of a rat prolactin minimal promoter (42) various expression plasmids on HIV-1 LTR-melinked to the firefly luciferase gene and is transcriptionally reption in three colon epithelial cell lines. SW620
sponsive to PMA in SW620 cells (Fig. 5 B) . Similarly, in T84 r), and T84 (right) colon epithelial cells were cocells transfected with the TRE/AP1-LUC reporter gene, a g of the -91/ +232 CAT reporter plasmid together nearly sixfold stimulation of luciferase activity was noted in ression vectors indicated. Cells either received no response to PMA stimulation (Fig. 5 B) (Fig. 5 A) plete LTR sequences upstream of +80 but lacking a fully transcribed noncoding 5' leader sequence was transfected into SW620 or T84 cells, a strong PMA response was detected in SW620 cells, but not in T84 cells under identical conditions (Fig. 5 B) . PMA-treated T84 cells were also unable to activate a full-length LTR CAT construct that included downstream LTR sequences to nucleotide position +232 or a full-length proviral clone (data not shown). These data are consistent with our previous results, indicating that T84 cells are unable to mediate PMA activation of the HIV-l LTR (18) . Although T84 cells can transmit PMA activation signals to AP-1-dependent reporter genes, they are apparently deficient in the intracellular signaling that is required to trigger the activation ofthe HIV-l LTR by PMA.
Downstream sequence motifs weakly bind recombinant cJun protein. Having documented the importance of the DSE motifs in c-Fos transactivation of the HIV-1 LTR, we next assessed their AP-l binding properties. Because c-Fos itself does not bind DNA, we performed gel mobility shift experiments with purified recombinant trpE-c-Jun fusion protein, which, as a major component of AP-1 complexes, was previously shown to bind with high affinity to a classical TRE motif (26) . When increasing amounts of trpE-c-Jun were incubated with an HIV-1 LTR restriction fragment (+80/+222) containing the DSE motifs, a specific gel shift complex was formed (Fig. 6 A, lane 5) . This c-Jun-DNA complex migrated near a TRE deoxyoligonucleotide c-Jun binding complex, but displayed less binding activity (compare Fig. 6 A, lanes 1 and 5) . To assess whether c-Jun could bind to the HIV-l DSE sites, we synthesized a series of short double-stranded deoxyoligonucleotides containing the TRE/CRE-like motifs (Table I ). In the gel mobility shift assays shown in Fig. 6 B, an oligonucleotide containing the + 160 DSE-2 motif formed specific complexes with trpE-c-Jun (Fig. 6 B, lanes 2 and 3) that comigrated with complexes formed on the collagenase TRE oligonucleotide control (Fig. 6 B, lane 1) , albeit with less binding activity. In contrast, an oligonucleotide with a mutation in the + 160 motif (+ 160m) formed no detectable trpE-c-Jun complexes (Fig. 6 B, lanes 4 and 5) . The +95 DSE-1 oligonucleotide formed only weakly detectable complexes with trpE-c-Jun (Fig. 6 B, lanes 6 and 7) . These results indicate that, although c-Jun can recognize and bind the downstream + 160 and +95 DSE motifs, it does so less efficiently than to a classical TRE oligonucleotide.
To more accurately assess the relative binding affinities of the various oligonucleotides for c-Jun, increasing amounts of unlabeled + 160, + 160m and +95 DSE oligonucleotides were competed for trpE-c-Jun binding with the labeled collagenase TRE oligonucleotide (Fig. 6 C) . In accordance with their apparent binding efficiencies documented in Fig. 6 B, the + 160 DSE-2 oligonucleotide competed with the TRE oligonucleotide for c-Jun binding (Fig. 6 C, lanes 5 and 6) better than the +95 DSE-l oligonucleotide (lanes 9 and 10), or the +160m DSE-2 oligonucleotide (lanes 7 and 8) . However, the homologous collagenase TRE oligonucleotide was a substantially better competitor than any ofthe HIV-1 LTR derived oligonucleotides (Fig. 6 C, lanes 1-3) . T84 cell nuclear extracts produce a distinct gel shift pattern of CRE motif binding activity. To identify the DNA binding activities present in colon epithelial cells that recognize HIV-l LTR sequence motifs, we prepared cell-free nuclear extracts (44) from T84, SW620, and HT29 cells, incubated them with labeled oligonucleotide sequence motifs, and resolved DNA binding complexes by gel electrophoresis (Fig. 7) . Fig. 7 A shows that specific gel shift complexes form with oligonucleotides containing SpI (lanes 1-3) and NFl binding sites (lanes 4-6). Spl and NFl are common transcription factors present in a wide variety of cell types and their binding sites are found in many cellular and viral promoters, including HIV-1 (4, 39); their similar DNA-binding activities among the three cell lines provide, therefore, an indication of the quality of the colonic cell nuclear extracts.
Because the downstream motifs in the HIV-l LTR closely resemble consensus TRE and CRE motifs, we tested each cell extract for DNA binding activity to oligonucleotides with a classical TRE (20, 21 ) or CRE (30) motif (Table I) . Although classical TRE and CRE motifs are nearly identical in primary sequence, the collagenase TRE motifis a strong binding site for members of the Jun/Fos family, whereas the somatostatin CRE motifis a preferential binding site for CREB/ATF family members (20, 21, 30) . The gel shift data shown in Fig. 7 B indicate that each ofthe three colon epithelial cell lines contain separate CRE (lanes 1-3) and TRE (lanes 4-6) binding activities that do not cross compete (lanes 2 and 6). Although the individual CRE and TRE complexes each exhibit a similar gel migration pattern with all three cell nuclear extracts, the relative DNA binding activity of one of the two major complexes formed with the CRE oligonucleotide was different with the nuclear extract ofT84 compared with SW620 and HT29 cells. The faster-migrating CRE complex with T84 cell nuclear extract was markedly reduced compared with the slower-migrating CRE complex and compared with the CRE complexes formed with identical amounts of SW620 and HT29 cell nuclear extract (Fig. 7 B, lanes 1-3) . Together, these data indicate that the DNA binding activities in colon epithelial cells are very similar; the one notable exception being the CRE binding activity in T84 cells, which appears to be deficient in the faster-migrating CRE gel shift complex.
Downstream sequence elementsform novel c-fos-containing complexes with colonic epithelial cell proteins. To further assess the DNA binding activity of the TRE/CRE-like motifs in the HIV-l LTR, we performed gel mobility shift experiments including oligonucleotides containing the + 160 and +95 DSE motifs (Table I) . The results in Fig. 8 show that a specific DNA binding activity can be detected with the + 160 and +95 DSE oligonucleotides in nuclear extracts from each of the colon epithelial cell lines (Fig. 8 A, lanes I and 5) . The DNA binding activity detected with the T84 cell nuclear extract was, however, weak compared with the relative binding activity generated by identical amounts ofSW620 or HT29 cell nuclear extracts. When unlabeled oligonucleotides were used to compete for complex formation, the unlabeled collagenase TRE oligonucleotide did not interfere with the formation of either the +95 or + 160 DSE gel shift complexes (Fig. 8 A, lanes  2 and 6) . In contrast, the somatostatin CRE oligonucleotide blocked the formation of these gel shift complexes (Fig. 8 A,  lanes 3 and 7) to a degree similar to or better than that of homologous competition with the +160 or +95 oligonucleotide (lanes 4 and 8) . These results indicate that the DNA binding proteins in colonic epithelial cells that recognize the HIV-I LTR DSE also recognize a classical CRE motif.
Using the SW620 nuclear extract, the gel shift complex formed on the + 160 DSE-2 oligonucleotide clearly migrates faster in the gel than the complex formed on the collagenase (Table I) 10) . Migration of the free unbound TRE probe (bottom arrow) and the c-Jun-TRE oligonucleotide complexes (top arrow) are indicated.
TRE oligonucleotide (Fig. 8 B, lanes I and 2) . In contrast, the + 160 DSE-2 complex comigrated with the faster migrating complex formed on the somatostatin CRE oligonucleotide (Fig. 8 B, lane 7) , which, interestingly, was the same complex as the one preferentially reduced when using T84 cell extracts ( Fig. 7 B) . Again, the collagenase TRE oligonucleotide did not compete for formation of the + 160 DSE-2 complex (Fig. 8 B,  lane 3) nor did a TRE/CRE-related oligonucleotide, phorbol ester inhibitory element (PIE) ( Table I) 5, and 6).
the somatostatin CRE motif reduced formation of the + 160 DSE gel shift complex (Fig. 8 B, lane 4) again to an extent similar to that seen with the homologous oligonucleotide (lane 6) . Identical results were obtained with the +95 DSE-1 oligonucleotide (data not shown).
To determine whether c-Fos was a component ofthe CRElike DSE gel shift complex, a c-Fos antibody (1 8C3) that was previously shown to specifically interfere with c-Fos-containing complexes (47) was included in the binding reactions before adding DNA probe (Fig. 8 C) . Since the c-Fos gene is induced by serum, for these gel shift experiments SW620 serum-starved extracts were used to assess whether the DSE complex would be affected. As shown in Fig. 8 C, the c-Fos antibody blocked the formation ofthe CRE-like DSE complex (lane 2, complex I). Interestingly, using serum-starved extracts, a new complex was also formed that migrated slower in the gel than the CRE-like DSE complex (Fig. 8 C, lane 1, complex II) . This new complex was also somewhat diminished by the anti-c-Fos antibody (lane 2, complex II). c-Fos antibody was specific for the comigrating complex shared by the DSE and the CRE, as shown in Fig. 8 C, lanes 3 and 4, since it was able to block only the faster migrating CRE complex (lane 4). Thus, although the HIV-l DSE motifs can form more than one gel shift complex, the faster-migrating complex appears to be a c-Fos-containing CRE-like binding complex.
Discussion
We describe DSE in the transcribed noncoding 5' leader sequences of the HIV-1 LTR that are c-Fos responsive and are differentially activated in three human colon carcinoma epithelial cell lines. One or both ofthe DSE, shown in relation to the HIV-I LTR in Fig. 1 A and at the nucleotide level in Fig. 3 A, mediate c-Fos transactivation of the HIV-1 LTR in colonic epithelial cells stimulated with PMA or TNFa. These are the most downstream cis-regulatory elements described thus far in the HIV-1 LTR. These findings suggest that previously unrecognized sequence elements that reside downstream of TAR in the transcribed noncoding 5' leader sequence may contribute to the activation and regulation of HIV-1 gene expression.
Role ofthe c-Fos-responsive DSE sites in the activation of the HIV-1 LTR. The first downstream element, DSE-1, is located immediately downstream of TAR at nucleotide position +95 and appears to be composed of two partially overlapping TRE/CRE-like sites. DSE-2, the other HIV-1 c-Fos-responsive element, is located at position +160 and has perfect sequence identity to the functional AP-l binding sites found in the 72-bp repeats of SV40 and the enhancer region ofpolyoma virus (TTAGTCAG) (48) . The DSE-2 site is also identical to two of the three PMA-responsive elements recently identified in the HIV-1 pol gene, which are thought to comprise a potential HIV-1 intragenic enhancer element (49) [64] , which encodes a leucine zipper factor similar to c-Fos, and the X protein of hepatitis B virus [41] , which can form complexes with ATF proteins [65 ] ).
Intracellular signaling pathways that activate the c-Fos-responsive DSE sites appear to differ among human colonic epithelial cells. As an immediate early gene, c-Fos plays a crucial role in the intracellular transduction ofextracellular stimuli; its activation, along with c-jun, is important for entry into the cell cycle (23 Differential c-Fos transactivation of SW620, HT29, and T84 cells correlates with a novel CRE-like binding activity in colon epithelial cells. The ability of c-Fos to transactivate expression of the HIV-1 LTR in human colon epithelial cells correlated with a CRE-like binding activity. In the T84 cell extracts, one of the CRE complexes was weakly detected compared with its counterpart in the HT29 and SW620 cell extracts. This latter CRE complex comigrated with those formed on the DSE motifs. In addition, the comigrating CRE and DSE complexes were blocked when incubated with an anti-c-Fos monoclonal antibody ( 1 8G3), shown previously to specifically interfere with c-Fos-containing gel shift complexes (47) . The second CRE complex, which does not comigrate with the DSE complex, was unaffected by the antibody. Thus, c-Fos is a component ofboth the CRE and DSE complexes. This is consistent with studies demonstrating that, as a heterodimer, c-Fos binds to CRE as well as TRE (25, 33) . It also suggests that the c-Fos transactivation ofthe HIV-1 LTR is most likely due to a direct interaction of c-Fos with the DSE motifs.
Although cotransfections with the c-Fos expression plasmid resulted in high levels of transcriptional activity from a construction containing the HIV-l DSE motifs, different combinations of other members of the Jun/Fos family failed to stimulate comparable levels of HIV-1 LTR expression in PMA-or TNFa-stimulated colon epithelial cells. Because Jun forms a more stable complex as a heterodimer with Fos than as a Jun-Jun homodimer, in many cell systems c-Jun cotransfected with c-Fos stimulates higher levels of gene expression than c-jun alone ( 19, 25, 27) . However, in the colonic epithelial cells, cotransfected c-Jun reduced expression of the HIV-l LTR stimulated by c-Fos transactivation. Because c-Fos requires a partner to bind DNA as a heterodimer ( 19), it is conceivable in our studies that c-Jun displaced, by a direct competition or squelching mechanism, the protein dimerization partner that combines with c-Fos to form the HIV-1 DSE activation complex. This putative dimerization partner of c-Fos might be a member ofthe CREB/ATF family that cross-combines with c-Fos to form a hybrid dimer with an altered sequence binding specificity in which CRE-like, rather than TRE-like, sequences are preferred (32) (33) (34) (70) . It is also possible that c-Fos interacts with non-AP-1/CREB/ATF proteins, such as those from the C/EBP and NF-IL6 basic-leucine zipper family (71) .
